Angiotech Expands and Reworks Baxter COSEAL Deal (for real)
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) reworked its COSEAL deal with Baxter International Inc. For a $25 million one-time payment, Baxter will pick up the rights to COSEAL in Japan,...
View ArticleThe Partnering Process – Deal Structure: Part 18 of Valuation and Other...
[Ed. This is the eighteenth part in Wayne's series. You can access the whole thing by clicking here. Please leave comments or questions on the blog and Wayne will address them in future posts in this...
View Article
More Pages to Explore .....